Fluoxetine + outpatient cognitive behavioral therapy
NIDA-13176-1
Approved small_molecule completed
Quick answer
Fluoxetine + outpatient cognitive behavioral therapy for Alcohol-Related Disorders is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Alcohol-Related Disorders
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed